These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30427511)

  • 1. Complex proteinopathies and neurodegeneration: insights from the study of transmissible spongiform encephalopathies.
    Piccardo P; Asher DM
    Arq Neuropsiquiatr; 2018 Oct; 76(10):705-712. PubMed ID: 30427511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for prion-like diseases.
    Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
    Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quaking-induced conversion of prion protein on a thermal mixer accelerates detection in brains infected with transmissible spongiform encephalopathy agents.
    Kaelber N; Bett C; Asher DM; Gregori L
    PLoS One; 2019; 14(12):e0225904. PubMed ID: 31830760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transmissible spongiform encephalopathies of livestock.
    Greenlee JJ; Greenlee MH
    ILAR J; 2015; 56(1):7-25. PubMed ID: 25991695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could intracrine biology play a role in the pathogenesis of transmissable spongiform encephalopathies, Alzheimer's disease and other neurodegenerative diseases?
    Re RN
    Am J Med Sci; 2014 Apr; 347(4):312-20. PubMed ID: 24185262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amyloid aggregates: role in Protein Misfolding Disorders].
    Duran-Aniotz C; Moreno-Gonzalez I; Morales R
    Rev Med Chil; 2013 Apr; 141(4):495-505. PubMed ID: 23900371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
    Jeffrey M
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies.
    Scallet AC; Ye X
    Ann N Y Acad Sci; 1997 Oct; 825():194-205. PubMed ID: 9369987
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid aptamers for neurodegenerative diseases.
    Bouvier-Müller A; Ducongé F
    Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mayhem of the multiple mechanisms: modelling neurodegeneration in prion disease.
    Brown DR
    J Neurochem; 2002 Jul; 82(2):209-15. PubMed ID: 12124421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
    Bayer TA
    Eur Neuropsychopharmacol; 2015 May; 25(5):713-24. PubMed ID: 23642796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
    Jaunmuktane Z; Brandner S
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into Mechanisms of Chronic Neurodegeneration.
    Diack AB; Alibhai JD; Barron R; Bradford B; Piccardo P; Manson JC
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
    Eraña H; Venegas V; Moreno J; Castilla J
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies.
    Singh S; DeMarco ML
    J Appl Lab Med; 2020 Jan; 5(1):142-157. PubMed ID: 31811072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Prion-like" templated misfolding in tauopathies.
    Clavaguera F; Lavenir I; Falcon B; Frank S; Goedert M; Tolnay M
    Brain Pathol; 2013 May; 23(3):342-9. PubMed ID: 23587140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.